Evidence map›Paper›PMID 42265431›Full record

ArticleLung2026

Worsened longitudinal visit-to-visit-FEV

Marie-Hélène Walraedt, Amber Vanhauwaert, David G Goldfarb, Hillel W Cohen, David J Prezant, Lies Lahousse, Michael D Weiden

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marie-Hélène WalraedtDepartment of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, 9000, Belgium.ORCID https://orcid.org/0009-0005-5347-7659
Amber VanhauwaertDepartment of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, 9000, Belgium.
David G GoldfarbThe FDNY World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, 11201, USA.ORCID https://orcid.org/0000-0003-2682-7543
Hillel W CohenDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID https://orcid.org/0000-0002-4524-0898
David J PrezantThe FDNY World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, 11201, USA.ORCID https://orcid.org/0000-0001-9562-0330
Lies LahousseDepartment of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, 9000, Belgium.ORCID https://orcid.org/0000-0002-3494-4363
Michael D WeidenThe FDNY World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, 11201, USA. Michael.Weiden@nyulangone.org.ORCID https://orcid.org/0000-0001-7419-0757

Funding

NIOSH CDC HHS 1R21OH012958NIOSH CDC HHS 1R21OH012958-01NIOSH CDC HHS R21 OH012958
6 · The paper itself

Abstract

introductionThe World Trade Center (WTC) collapse produced an inhalation disaster. Body Mass index (BMI) is a risk-factor for WTC-related lung injury. Visit-to-visit-forced-expiratory-volume-at-one-second-variation (FEV

methodsAnnual WTC-monitoring measured lung function and weight. FEV

resultsFourty-seven percent (4459/9410) of WTC-exposed FDNY-workers experienced worsened-FEV

interpretationWorsened-FEV

Indexed as

Occupational ExposureSeptember 11 Terrorist AttacksAdultBody Mass IndexCross-Sectional StudiesFemaleForced Expiratory VolumeHumansLongitudinal StudiesMaleMiddle AgedNew York CityRisk FactorsTime FactorsBody Mass Index TrajectoryFEV1 variation trajectoryMortalityWorld Trade Center Exposure

Identifiers

PMID42265431
PMCPMC13249727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.